Carlisle Companies Inc, known as CSL Limited, is a global leader in biopharmaceuticals and vaccines, with a rich history dating back to 1916. Based in Melbourne, Australia, CSL operates in key markets including the US, Germany, the UK, Switzerland, and China. The company is structured into three main segments: CSL Behring, focusing on plasma products, gene therapies, and recombinants; CSL Seqirus, specializing in influenza vaccines and pandemic services; and CSL Vifor, dedicated to iron deficiency and nephrology therapies. CSL also actively licenses its intellectual property, contributing to its reputation as a pioneer in medical science.
Companies that have raised dividends for shareholders for 50 years or more are the kinds of investments passive income investors need to own. Dependability is crucial for individuals seeking to increase their…
The Goldman Sachs Conviction List is a curated list of stocks that the firm’s research team believes are highly likely to outperform the market. It’s a tool for investors to identify stocks…
Large-cap growth stocks have dominated for so long because most investors have stopped looking at anything else. The thinking here is pretty simple in that why would you bother with mid-caps or…
Wednesday's top analyst upgrades and downgrades included AMC Entertainment, Bumble, Comerica, Dell Technologies, Edwards Lifesciences, Etsy, Fisker, Luminar Technologies, Micron Technology, Opendoor Technologies, Pinterest and Snap.
Monday's top analyst upgrades and downgrades included Altria, Amazon.com, Apple, Axalta Coating Systems, Comcast, Etsy, Intel, McDonald's and Medical Properties Trust.
Monday's top analyst upgrades and downgrades included Coca-Cola, Datadog, Domino’s Pizza, Enphase Energy, Harley-Davidson, Johnson & Johnson, Liberty Global, Microsoft, Nasdaq, Nike, Tesla and Workday.
Thursday’s top analyst upgrades and downgrades included Amgen, Apollo Global Management, Baidu, Best Buy, Charles Schwab, ChargePoint, Chewy, CrowdStrike, Datadog, First Solar, Fiserv, Monster Beverage, Rocket Lab, Signify Health, Visa and Welltower.
Wednesday's top analyst upgrades and downgrades included Allbirds, Amazon.com, American Eagle Outfitters, Canopy Growth, Citizens Financial, Cleveland-Cliffs, Etsy, Deere, LyondellBasell Industries, Medtronic, PayPal, Steel Dynamics and Truist Financial.
Monday's top analyst upgrades and downgrades included Amazon.com, Apple, Caterpillar, Comcast, Comerica, Gilead Sciences, Intel, Lululemon Athletica and McDonald's.
Wednesday's top analyst upgrades and downgrades included AbbVie, Blackstone, Boston Scientific, CarMax, Chewy, Eli Lilly, Medtronic, NetApp, Ping Identity, Shopify, Veru and Zscaler.
Chesapeake Energy, Dick's Sporting Goods, Sempra Energy and Unity Software were among Wednesday afternoon's analyst calls.
Friday's top analyst upgrades and downgrades included Citrix Systems, CRISPR Therapeutics, Dunkin' Brands, Fastly, Intel, Mattel, PulteGroup, Sirius XM, Southwest Airlines Tesla and Under Armour.
Credit Suisse has made seven additions to its list of top picks. They are listed as having the "highest conviction combined with the least demanding market expectations."
Friday's top analyst upgrades and downgrades included Darden Restaurants, DuPont, EOG Resources, Lululemon Athletica, Micron Technology, Occidental Petroleum, Slack, Spotify, Ulta Beauty and Walt Disney.
The top analyst upgrades, downgrades and initiations seen on Monday included Best Buy, Emerson Electric, Genpact, IBM, Lululemon Athletica, Manchester United, Sherwin-Williams and SCANA.
